Skip to main content
Download PDF

The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA

BMC Oral Health volume 23, Article number: 85 (2023) Cite this article

Abstract

Background

Common chronic infections induced low-grade inflammation has been correlated with atherosclerosis as supported by strong evidence. The balance between pro-and anti-inflammatory factors was exploited to elucidate the effects of chronic periodontitis on diabetes-associated atherosclerosis.

Methods

Study subjects encompassed 30 SPF male rats randomly divided into four groups: A group (NC), B group (T2DM), C group (CP), D group (DM + CP). After developing the model, blood samples were collected from the angular vein analyze serum APN, hs-CRP, and blood lipid. the carotid artery was isolated for HE staining.

Result

Compared with group A, the serum APN in group B, C and D decreased gradually with the progression of the disease. Serum hs-CRP in group B, C and D was significantly increased. At T3, T4 and T5 in group B, C and D, APN/hs-CRP significantly decreased. TC, LDL and TG significantly increased in group B, D; HDL significantly decreased in group C. Carotid artery HE staining showed: compared with group A, different degrees of endothelial defect, destruction of elastic fibers in the middle membrane, disorder of smooth muscle arrangement, and partial dissolution 、 fragmentation and Calcium salt deposition necrosis occurred in group B, C and D.

Conclusion

Enhanced systemic inflammation, decreased adiponectin level, and disorganized lipid metabolism with or without type 2 diabetes attributed to local inflammation of periodontitis can result in an imbalance of pro-inflammatory and anti-inflammatory effects. Therefore, it’s more meaningful to predict the progression of DAA with anti-inflammatory/pro-inflammatory variation.

Peer Review reports

Introduction

Macrovascular complications, as one of the major complications of Type 2 Diabetes Mellitus (T2DM), are the primary cause of disability, with a mortality rate of 65–75% [1]. Strong evidence substantiates the association of low-grade inflammation with many chronic diseases, for example, obesity, diabetes mellitus, atherosclerosis, and chronic periodontitis [2,3,4]. The incidence of periodontitis is as high as 60–70% in China. Periodontitis is a multifactorial, chronic inflammatory disorder with non-reversible damage to tooth-supporting tissues (gingiva, periodontal ligament, alveolar bone), leading to tooth mobility, tooth loss, and concomitant effects on oral function and life quality [5]. The continuous low-grade infection allows the microorganisms and virulence factors to enter the circulation and lead to systemic inflammation [6] and therefore, periodontitis is regarded as a risk factor for diabetes mellitus, cardiovascular, and cerebrovascular diseases [7,8,9,10]. Many evidence suggests that both T2DM and AS are chronic inflammatory diseases and are driven by inflammation [11, 12].

Adiponectin/APN, also known as ACRP30 (Adipocyte complementary related 30Kda protein), is a specific fatty molecule secreted by adipose tissue [13]. Adiponectin exerts its biological role by binding to seven transmembrane receptors, adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2), which are coupled to two structurally and functionally different G proteins [14]. Reduced expression of adiponectin and its cell surface receptors are linked with obesity, obesity-related insulin resistance, and chronic inflammatory status of diabetes [15]. Clinical studies confirmed the association of atherosclerosis with adiponectin [16]. A negative correlation of APN with inflammatory cytokine is attributed to the inhibition of TNF-α stimulated IL-8 synthesis in endothelial cells by regulating the NF-κB signaling pathway [17]. Wei Qiu et al. [18] found that APN receptor agonist AdipoAI impedes lipopolysaccharide-induced endotoxemia and other inflammatory diseases by triggering different signaling pathways.

The acute-phase reactant C-reactive protein (CRP) has long been considered a useful marker of inflammation. The vital role of CRP is also noted in host defense against invading pathogens and inflammation. Many studies have highlighted CRP as an independent cardiovascular predisposing factor, independent of high cholesterol and LDL [19]. Moreover, the prognosis of cardiovascular disease can be improved by reducing CRP levels [19].

Periodontitis is a common and highly frequent local inflammatory disease. Nonetheless, the mechanism of promoting diabetes-related atherosclerosis is ambiguous. Studies have substantiated the close relation of both APN and PCR to the progression and prognosis of atherosclerosis. However, there are limited studies that address the role of the balance between the anti-inflammatory effects of APN and the pro-inflammatory effects of CRP in atherosclerosis.

Materials and methods

Animals

Twenty-eight 6-week-old SD male rats weighing 180–200 g were purchased from the animal center of Shanxi medical university. All rats were maintained under standard housing conditions following the protocol approved by the Institutional Committee for Animal Use and Care at Shanxi medical university (No.2018LL346). Arrive Statements: (i) identifying the institutional and/or licensing committee approving the experiments, including any relevant details; (ii) confirming that all experiments were performed in accordance with relevant guidelines and regulations. All rats were randomly divided into the following groups: control rats (A group n = 7), T2DM rats (B group n = 7), periodontitis rats (C group n = 7), T2DM + CP rats (D group n = 7).

Modeling

T2DM: at 8 weeks of age, rats in the B group and D group were provided Western diet (Homemade: 20% sucrose + 10% lard + 2.5% cholesterol + 1% pig bile salt + 66.5% basal feed), multiple low doses of streptozotocin(STZ, Sigma–Aldrich, USA) (25 mg/kg) were injected intraperitoneally, and dynamic monitoring of blood sugar, Model standard: FPG > 7.8 mmol/L, or PBG ≥ 17.8 mmol/L (Fig. 1a).

Fig. 1
figure 1

Timeline of this work. a, b The experimental time schedules of the diabetes mellitus (DM) group and chronic periodontitis (CP) group, respectively

Full size image

CP: the experimental teeth (bilateral maxillary first and second molar) were ligated under general anesthesia with Oral ligation wire and 3–0 silk thread. A week later, P. g suspension was applied once every 3 days and checked regularly. The bacteria were applied a total of 15 ~ 20 times. The standard strain of Porphyromonas gingivalis (Pg) was provided by the Laboratory of Oral Microbiology of Capital Medical University (ATCC33277), which was mixed to a concentration of 1 106 CFU mL–1 and used on the same day (Fig. 1b).

T2DM + CP: the periodontitis model of rats was established at the early stage of the Western diet. After developing the model successfully, the rats continued to be fed.

Explanations and Instructions: T1, T2, T3, T4, T5:

The experiment was divided into: control, CP, DM, CP + DM, of this groups When the modeling is successful, T1 (1 week before the first intervention), T2 (1 week after the first intervention), T3 (1 week after the second intervention), T4 (3 weeks after the second intervention), T5 (5 weeks after the second intervention), These time nodes are the time points of intervention for Group CP, DM + CP, the groups covered in this article are natural progression groups, another part of the study was to compare the natural progression at each time node with that after the intervention.

Detection indicators and methods

After inducing the models successfully, the inflammatory index hs-CRP (ELISA kit, Shanghai Xitang Co., LTD.), adipic factor APN (ELISA kit,Shanghai Xitang Co., LTD.), the collected serum samples to be tested were removed from − 80 °C and returned to room temperature. 1:5 dilution of specimen dilution was used during the experiment (20ul sample was taken and 80ul specimen dilution was added) and blood lipids: TC (TC Assay Kit, Di Rui Medical Technology Co., LTD, CHOD—PAP, sample size: 3ul), LDL (Direct—surfactant removal method, sample size: 4ul),TG (Direct—catalase clearance method, sample size: 3 µl), HDL (GPO-PAP, sample size: 4 µl), were measured at different time points in the natural process. Finally, the rats were sacrificed (at 26 weeks) (anesthesia of animals is Pelltobarbitalum Natricum through intraperitoneal injection anesthetization) to isolate bilateral carotid arteries. The vascular tissues of about 1 cm above and below the bifurcation of bilateral carotid arteries of rats were separated. After soaking in normal saline, the left side was placed in neutral formalin solution and fixed for 24–48 h. The left side was embedded in paraffin wax and cross-sectional sections were performed with thickness of 4 μm, two slices were cut continuously from each slide and observed under light microscope after HE staining.

Statistical analysis

All the data were represented by the figures. Data were presented as mean ± SD. SPSS software (version 21) was adopted for the statistical analysis. To determine the significance, one-way ANOVA with Tukey’s post-hoc test was employed for multi-group comparisons. Statistical significance was set at p < 0.05.

Result

Establishment of T2DM model and the loss of alveolar bone

Following two weeks of adaptive feeding, SD rats were fed with Western food for 4–6 weeks, and thereafter, multiple intraperitoneal injections of low-dose STZ (25 mg/kg) were administered, and fasting plasma glucose or random blood glucose was monitored. Model standard: FPG > 7.8 mmol/L, or RBG ≥ 17.8 mmol/L (Fig. 2).

Fig. 2
figure 2

Fasting plasma glucose or random blood glucose was monitored. Model standard: FPG > 7.8 mmol/L, or PBG ≥ 17.8 mmol/L

Full size image

The distances from the cement-enamel junction (CEJ) to the alveolar bone crest of the tooth were measured at three points (mesial, medial, and distal aspects), both in the buccal and lingual sides. The measurements of each point were repeated three times, and the mean was computed. The mean crystal bone level of the tooth was calculated (Fig. 3a, b).

Fig. 3
figure 3

Bone resorption values of alveolar bone in each group. The CEJ value of alveolar bone in group B, C and D was significantly increased. a Normal control; b DM; c chronic periodontitis; d DM + CP, compared to group A, *p < 0.05.

Full size image

Effect of adiponectin, hs-CRP on periodontitis with or without type 2 diabetes in rats

Disease progression documented a gradual reduction in the level of APN in groups B, C, and D. Serum adiponectin levels in group B decreased gradually with the progression of the disease, though the difference was statistically insignificant (p > 0.05). Compared to the A group, the significantly higher (p < 0.05) APN level in group C at T1, T2, may be related to acute inflammation in the early modeling of periodontitis. On the contrary, at T3, T4, T5, the level of APN was significantly lower in groups C and D (p < 0.05) compared to group A (Table 1, Fig. 4a, b). The inflammatory factor hs-CRP in natural process was higher in groups B, C, and D, relative to group A. Serum hs-CRP gradually increased with the natural progression of the disease, but group B manifested no statistical difference (p > 0.05) (Table 2, Fig. 5a, b).

Table 1 Serum APN values of each group during natural process (n = 7, \(\overline{x}\) ± s, unit: ng/ml)
Full size table
Fig. 4
figure 4

Disease progression documented a gradual reduction in the level of APN in groups B, C, and D. Serum adiponectin levels in group B decreased gradually with the progression of the disease, though the difference was statistically insignificant (p > 0.05). Compared to the A group, the significantly higher (p < 0.05)

Full size image
Table 2 Serum hs-CRP values of each group during natural process (n = 7, \(\overline{x}\) ± s, unit: ng/ml)
Full size table
Fig. 5
figure 5

The inflammatory factor hs-CRP in natural process was higher in groups B, C, and D, relative to group A. Serum hs-CRP gradually increased with the natural progression of the disease, but group B manifested no statistical difference (p > 0.05)

Full size image

The ratio of APN/hs-CRP in each group

The ratio of APN/hs-CRP signified the balance between anti-inflammation and pro-inflammation. The results revealed, at T1, significantly lower (p < 0.05) ratio of APN/CRP in D group, but no significant difference (p > 0.05) in group B, C group as compared to A group; at T2, compared to A group, the ratio was significantly lower (c 0.05) in both B and D group. However, C group demonstrated no difference (p > 0.05); the ratio was significantly lower (p < 0.05) in the B, C, D group at T3, T4, T5, compared to A group. Overall, with the disease progression, the ratio of the B group failed to reflect any significant downward trend, whereas, C, D group manifested a gradual downward trend (Table 3; Fig. 6).

Table 3 The ratio of serum APN/CRP in each group (n = 7, \(\overline{x}\) ± s)
Full size table
Fig. 6
figure 6

The ratio of APN/hs-CRP signified the balance between anti-inflammation and pro-inflammation. The results revealed, at T1, significantly lower (p < 0.05) ratio of APN/CRP in D group, but no significant difference (p > 0.05) in group B, C group as compared to A group; at T2, compared to A group, the ratio was significantly lower (p < 0.05) in both B and D group. However, C group demonstrated no difference (p > 0.05); the ratio was significantly lower (p < 0.05) in the B, C, D group at T3, T4, T5, compared to A group. Overall, with the disease progression, the ratio of the B group failed to reflect any significant downward trend, whereas, C, D group manifested a gradual downward trend

Full size image

Serum lipid profile analysis

Disorders of lipid metabolism can induce the development of atherosclerosis. Our results revealed that compared to the A group, TG of group B, TC, LDL, TG of group D were significantly increased (p < 0.05). In the case of the C group, a significant decrease (p < 0.05) was obtained for HDL as compared to the A group. However, the other lipid indicators showed no significant difference (p > 0.05) (Table 4, Fig. 7).

Table 4 lipid values of each group during natural process (n = 7, \(\overline{x}\) ± s, unit: ng/ml)
Full size table
Fig. 7
figure 7

Serum lipid profile analysis. Compared to the A group, TG of group B, TC, LDL, TG of group D were significantly increased (p < 0.05). In the case of the C group, a significant decrease (p < 0.05) was obtained for HDL as compared to the A group. However, the other lipid indicators showed no significant difference (p > 0.05)

Full size image

Effects of periodontitis and diabetes on carotid artery in rats

A group: an intact intima, flattened endothelial cells, orderly arrangement of the elastic fibers and smooth muscle cells of the media, no thickening of the vessel wall were observed; B group: variation was noted in the blood vessel walls thickness, part of the endothelial cells were missing, the elastic fibers of the media were disordered, partially dissolved and fractured, and the smooth muscle cells were vacuolated; C group: the intima was incomplete, and some endothelial cells were exfoliated, the elastic fibers of the media were disordered, some of them were broken, and some specimens manifested calcium salt deposition; D group: the intima was incomplete, and some endothelial cells were missing, local necrosis of the smooth muscle tissue of the media was prominent, with amorphous particles and deepened staining, the elastic fibers in the necrotic area were disordered and some of them were broken (Fig. 8). These results suggest that periodontitis accelerates the lesion of carotid artery in diabetic rats.

Fig. 8
figure 8

HE staining results of carotid arteries in each group. A group: an intact intima, flattened endothelial cells, orderly arrangement of the elastic fibers and smooth muscle cells of the media, no thickening of the vessel wall were observed; B group: variation was noted in the blood vessel walls thickness, part of the endothelial cells were missing, the elastic fibers of the media were disordered, partially dissolved and fractured, and the smooth muscle cells were vacuolated; C group: the intima was incomplete, and some endothelial cells were exfoliated, the elastic fibers of the media were disordered, some of them were broken, and some specimens manifested calcium salt deposition; D group: the intima was incomplete, and some endothelial cells were missing, local necrosis of the smooth muscle tissue of the media was prominent, with amorphous particles and deepened staining, the elastic fibers in the necrotic area were disordered and some of them were broken

Full size image

Discussion

Our results reported a reduction in the serum APN of B, C, and D groups, especially a significant decrease in the C and D groups in comparison to group A. At the same time, the pathological changes of the carotid artery were witnessed in B, C, and D group, in particular, some endothelial cells in the carotid artery of the D group were shed and lost, local necrosis was evident in the smooth muscle tissue of the media, with amorphous particles and deepened staining, the elastic fibers in the necrotic area were disordered and some of them were broken. These results implied a negative correlation of chronic inflammatory disease with serum APN level, promoting the pathological alterations of atherosclerosis, but successful modeling of periodontitis in rats reflected a significant increase in the serum APN level, however, this significant increase was only seen in T2 and APN was significantly reduced thereafter.

Adiponectin is an endogenous bioactive protein produced by adipose, a specific fat molecule with anti-atherosclerotic, anti-inflammatory, and lipid regulatory properties. And periodontitis is a inflammatory disease and is also the sixth complication of diabetes. Uncontrolled periodontal inflammation gradually destructs the periodontal supporting apparatus and leads to the consequent loss of teeth. Recently, emerging evidence has revealed an association between APN and periodontitis. Iwayama et al. study demonstrate that adiponectin exerts anti-inflammatory effects on (human gingival fibroblasts, HGFs) and (mouse gingival fibroblasts, MGFs), and promotes the activities of osteoblastogenesis of(human periodontal ligament, HPDL) cells [20]. Xingwen Wu,et al. research results demonstrate that AdipoAI ameliorates the severity of T2D-associated periodontitis by enhancing autophagy in osteoclasts at lower doses [21]. As mentioned above, the underlying mechanisms may include the functions of APN in suppressing inflammation and promoting bone regeneration [22].

Other studies have shown that adiponectin contributes to the protection of endothelial cells [23]. Our study claimed a lower level of serum APN in the B group than that of the A group, which was further substantiated by the significant pathological changes of the carotid artery. Chen, Tao, et al. observed a significant decline (p < 0.001) in the serum APN level of type 2 diabetic patients with the macrovascular disease. Moreover, the prevalence of diabetic macrovascular disease gradually increased with the decrease of adiponectin [24]. Another meta-analysis documented a strong association of the elevated levels of inflammatory cytokines (IL-1β, Il-6, IL-18, CRP), TNF-α, and low levels of adiponectin with the risk of T2DM [25]. Philip M. Preshaw et al. [26] found that diabetes and periodontitis can simultaneously aggravate systemic inflammation, and the decrease of serum APN in patients was more obvious with diabetes combined with periodontitis. These reports were thus in agreement with our findings. Nonetheless, the value of serum APN was significantly elevated in the early modeling of periodontitis in our study. However, at present, there is limited research on APN secretion in the initial or acute stage of inflammation. There was a study of adiponectin in the early stages of acute systemic inflammation [27]. The results claimed that the plasma adiponectin level failed to alter following vaccination, but decreased after open-heart surgery, though there was no significant change in adiponectin gene expression in the omentum and subcutaneous [28]. However, adiponectin dysregulation has been reported in another associated systemic autoimmune rheumatic disease (SARDs) [29]. It is observed in SARDs with a high inflammatory component, such as rheumatoid arthritis and systemic lupus erythematosus, where APN serum levels are elevated [30, 31]. Circulating adiponectin is related to the imaging progression of rheumatoid arthritis [32]. A positive association of the cardiovascular risk of SLE with lupus nephritis has also been reported [33]. Nevertheless, in non-inflammatory SARDs, such as systemic sclerosis, APN levels are lower and negatively correlated with disease activity [34]. The accumulated evidence supports that APN is negatively associated with chronic inflammatory disease, but studies on the early secretion of acute inflammation have not been unified. Thus, further research needs to focus on this area.

Our study reported, increased the inflammatory factor hs-CRP was increased in B group, C group, and D groups, especially in C and D groups. Corresponding carotid pathologic changes also indicated the D group was the most severe. The levels of inflammatory cytokines were consistent with the results of carotid pathologic changes. These results confirmed that in addition to the effect of hyperglycemia on the artery in diabetic patients, the high level of inflammatory factors was also responsible for the pathological progression of blood vessels. A considerable contribution of the local inflammation of periodontitis to the inflammation level of the systemic system was also prominent.

As explored by Philip M. Preshaw et al. [26], diabetes combined with periodontitis group manifested a significantly increase in systemic inflammatory factors (IL-6, hs-CRP, TNF-α, IL-1β, IFN-γ), and periodontal treatment imparts a vital role in reducing systemic inflammation, which was in accordance with our findings. Our results obtained a negative correlation between serum adiponectin and hs-CRP levels, which signified that the treatment of periodontitis could reduce the levels of systemic inflammatory factors [26], increase serum adiponectin levels [35], delay the progression of diabetic insulin resistance and diabetic cardio-cerebrovascular complications. Furthermore, the anti-inflammatory property of adiponectin restricts the production of LPS-induced pro-inflammatory factors [18] and also reduces LPS-induced apoptosis [36].

As evident from our study, the progression of atherosclerosis is closely associated with both serum adiponectin and hs-CRP, but the balance of anti-inflammatory and pro-inflammatory factors are found to be more responsive to the inflammatory state of the system. Adamopoulos, Stamatis et al. [37] claimed the contribution of the balance of pro-inflammatory and anti-inflammatory cytokines to the improvement of left ventricular systolic function in dilated cardiomyopathy. The results confirmed that growth hormone-mediated effective regulation of the circulating cytokine network and soluble adhesion molecules in DCM patients, at the same time, strengthen the contraction reserve and reduce left ventricular volume. Wu Min et al. study revealed that compared with stable angina, higher levels of inflammatory factors and lower levels of anti-inflammatory factors were observed in patients with unstable angina and the change of pro-inflammatory/anti-inflammatory balance may represent the severity of coronary heart disease. In our study, a gradual reduction in the ratio of APN/hs-CRP was noted with the progression of the disease, compared to the A group, indicating deregulation of the balance of anti-inflammatory/pro-inflammatory with the advancement of the disease, especially in the compound group. Moreover, the arterial lesions in the compound group were more serious, suggesting that the ratio of APN/hs-CRP was consistent with the severity of the arterial lesions.

Atherosclerosis is a lipid-driven inflammatory disease of the lining of the arteries and the final clinical outcome depends on the balance of pro-inflammatory and inflammatory mitigation mechanisms. A large reduction in plasma LDL levels can lead to even severe atherosclerosis; plaque regression also minimizes the incidence of atherosclerotic cardiovascular disease [38]. Even though our results failed to obtain any statistically significant difference in TC, LDL, and TG between the C group and A group (p < 0.05), the HDL of the C group was significantly lower than that of the A group (p < 0.05). However, it is not completely consistent with the research results of Franca et al. [39], Nepomuceno et al. [40]. Franca's study reported significantly higher TC in the periodontitis group than in the normal control group. However, the diabetic periodontitis group demonstrated significantly elevated TC, LDL, and TG levels, while HDL, an anti-inflammatory lipoprotein, the combination of diabetes with periodontitis somehow prevented the HDL from significant decrease. In one prospective study of women, Small LDL and small HDLwere positively associated with diabetes, By contrast, large LDL and large HDL were inversely associated [41]. So HDL may inhibit development of T2DM by attenuating endoplasmic reticulum (ER) stress and apoptotic loss of pancreatic β-cells, an effect due in part to ABC transporter-mediated efflux of specific oxysterols with downstream activation of the hedghehog signalling receptor, Smoothened. The apoM-sphingosine-1-phosphate complex is critical to HDL antidiabetic activity, encompassing protection against insulin resistance, promotion of insulin secretion, enhanced β-cell survival and inhibition of hepatic glucose production [42]. Nepomuceno, R's meta-analysis results validated the significant correlation of PD with a decrease of HDL and an increase of LDL and triglyceride concentrations [40]; Only total serum HDL was measured in our experiment, It doesn't distinguish between large and small particles. Therefore, there are no clear results as to whether HDL promotes or inhibits diabetes progression as measured. Our study established the reduced anti-inflammatory effect of APN in the experimental group, while the pro-inflammatory factor hs-CRP was increased, especially in the periodontitis group and diabetic combined periodontitis group, destabilizing the pro-inflammatory and anti-inflammatory balance. The excess pro-inflammatory factor prompted the formation and progression of arterial plaque, thereby enhancing the prevalence of cardiovascular and cerebrovascular diseases.

Conclusion

Periodontitis is a common chronic inflammatory disease induced by periodontal pathogens. The local inflammation of periodontitis aggravates the systemic inflammatory factors. At the same time, significant reduction of the serum APN destabilizes the homeostasis of lipid metabolism, increasing TG, TC, and LDL levels, and reducing HDL levels, which, in turn, accelerated the formation of atherosclerotic plaques and escalated the incidence of cardiovascular and cerebrovascular diseases.

However, there is the fact that the current study assessed the mentioned variables in rats; other studies were on humans. Some of the differences between the results could be attributed to this fact. In addition, there are some other limits. We only illustrated the pathological changes of the carotid artery in the natural course of periodontitis, lacking the inflammatory markers and Carotid pathologic changes after periodontitis intervention, which will be studied in the next animal experiment.

Data availability

All data generated or analysed during this study are included in this published article.

References

  1. Shaw J, Sicree R, Zimmet P. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.

    Article  PubMed  Google Scholar 

  2. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Investig. 2017;127(1):1–4.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011;13(1):11–22.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505–22.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wang Q, Wu Z, Wu Y, Shu R, Pan Y, Xia J. Epidemiology and preventive direction of periodontology in China. J Clin Periodontol. 2007;34(11):946–51.

    Article  PubMed  Google Scholar 

  6. Cervino G, Fiorillo L, Laino L, Herford AS, Lauritano F, Giudice GL, et al. Oral health impact profile in celiac patients: analysis of recent findings in a literature review. Gastroenterol Res Pract. 2018;2018:7848735.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sumida K, Han Z, Chiu C-Y, Mims TS, Bajwa A, Demmer RT, et al. Circulating microbiota in cardiometabolic disease. Front Cell Infect Microbiol. 2022;12:892232.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Carnevale R, Sciarretta S, Valenti V, di Nonno F, Calvieri C, Nocella C, et al. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction. Eur Heart J. 2020;41(33):3156–65.

    Article  PubMed  Google Scholar 

  9. Cervino G, Cicciù M, De Stefano R, Falcomatà D, Bianchi A, Crimi S, et al. Oral health in patients with Marfan syndrome. Arch Oral Biol. 2020;116:104745.

    Article  PubMed  Google Scholar 

  10. Cervino G, Terranova A, Briguglio F, De Stefano R, Famà F, D'Amico C, et al. Diabetes: oral health related quality of life and oral alterations. Biomed Res Int 2019:5907195.

  11. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6(6):399–409.

    Article  PubMed  Google Scholar 

  12. Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circ Res. 2019;124(2):315–27.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Takeuchi S, Wada K, Uozumi Y, Otani N, Osada H, Nagatani K, et al. Adiponectin receptor 1 expression is associated with carotid plaque stability. Neurol India. 2013;61(3):249–53.

    Article  PubMed  Google Scholar 

  14. Yamauchi T, Iwabu M, Okada-Iwabu M, Kadowaki T. Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab. 2014;28(1):15–23.

    Article  PubMed  Google Scholar 

  15. van Stijn C, Kim J, Barish G, Tietge U, Tangirala R. Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS ONE. 2014;9(1):e86404.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Nakatsuji H, Kishida K, Sekimoto R, Komura N, Kihara S, Funahashi T, et al. Accumulation of adiponectin in inflamed adipose tissues of obese mice. Metabolism. 2014;63(4):542–53.

    Article  PubMed  Google Scholar 

  17. Saijo S, Nagata K, Nakano Y, Tobe T, Kobayashi Y. Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Commun. 2005;334(4):1180–3.

    Article  PubMed  Google Scholar 

  18. Qiu W, Wu H, Hu Z, Wu X, Tu M, Fang F, et al. Identification and characterization of a novel adiponectin receptor agonist adipo anti-inflammation agonist and its anti-inflammatory effects in vitro and in vivo. Br J Pharmacol. 2021;178(2):280–97.

    Article  PubMed  Google Scholar 

  19. Kalkman DN, Aquino M, Claessen BE, Baber U, Guedeney P, Sorrentino S, et al. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions. Eur Heart J. 2018;39(46):4101–8.

    Article  PubMed  Google Scholar 

  20. Iwayama T, Yanagita M, Mori K, Sawada K, Ozasa M, Kubota M, et al. Adiponectin regulates functions of gingival fibroblasts and periodontal ligament cells. J Periodont Res. 2012;47(5):563–71.

    Article  Google Scholar 

  21. Wu X, Sun Y, Cui R, Qiu W, Zhang J, Hu Z, et al. A novel adiponectin receptor agonist (AdipoAI) ameliorates type 2 diabetes-associated periodontitis by enhancing autophagy in osteoclasts. J Periodont Res. 2022;57(2):381–91.

    Article  Google Scholar 

  22. Wang Z, Chen Z, Fang F, Qiu W. The role of adiponectin in periodontitis: current state and future prospects. Biomed Pharmacother. 2021;137:111358.

    Article  PubMed  Google Scholar 

  23. Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, Fuchs D. Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem. 2010;17(36):4511–20.

    Article  PubMed  Google Scholar 

  24. Chen T, Tu M, Huang L, Zheng Y. Association of serum adiponectin with intima media thickness of dorsalis pedis artery and macroangiopathy in type 2 diabetes. J Diabetes Res. 2020;2020:4739271.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Liu C, Feng X, Li Q, Wang Y, Li Q, Hua M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine. 2016;86:100–9.

    Article  PubMed  Google Scholar 

  26. Preshaw PM, Taylor JJ, Jaedicke KM, De Jager M, Bikker JW, Selten W, et al. Treatment of periodontitis reduces systemic inflammation in type 2 diabetes. J Clin Periodontol. 2020;47(6):737–46.

    Article  PubMed  Google Scholar 

  27. Tukiainen E, Kylanpaa M-L, Ebeling P, Kemppainen E, Puolakkainen P, Repo H. Leptin and adiponectin levels in acute pancreatitis. Pancreas. 2006;32(2):211–4.

    Article  PubMed  Google Scholar 

  28. Ekström M, Söderberg S, Tornvall P. Acute systemic inflammation is unlikely to affect adiponectin and leptin synthesis in humans. Front Cardiovasc Med. 2015;2:7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Toussirot É, Binda D, Gueugnon C, Dumoulin G. Adiponectin in autoimmune diseases. Curr Med Chem. 2012;19(32):5474–80.

    Article  PubMed  Google Scholar 

  30. Zhang Y, Johansson L, Andersson-Assarsson J, Taube M, Peltonen M, Svensson P-A, et al. Adiponectin associates with rheumatoid arthritis risk in overweight and obesity independently of other adipokines. J Clin Med. 2021;10(13):2791.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Chougule D, Nadkar M, Venkataraman K, Rajadhyaksha A, Hase N, Jamale T, et al. Adipokine interactions promote the pathogenesis of systemic lupus erythematosus. Cytokine. 2018;111:20–7.

    Article  PubMed  Google Scholar 

  32. Qian J, Xu L, Sun X, Wang Y, Xuan W, Zhang Q, et al. Adiponectin aggravates bone erosion by promoting osteopontin production in synovial tissue of rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):26.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Carbone F, Montecucco F, Poggi A, Nobili F, Cacciapaglia F, Afeltra A, et al. Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus. Nutr Metab Cardiovasc Dis. 2020;30(7):1147–51.

    Article  PubMed  Google Scholar 

  34. Brezovec N, Perdan-Pirkmajer K, Čučnik S, Sodin-Šemrl S, Varga J, Lakota K. Adiponectin deregulation in systemic autoimmune rheumatic diseases. Int J Mol Sci. 2021;22(8):4095.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Bharti P, Katagiri S, Nitta H, Nagasawa T, Kobayashi H, Takeuchi Y, et al. Periodontal treatment with topical antibiotics improves glycemic control in association with elevated serum adiponectin in patients with type 2 diabetes mellitus. Obes Res Clin Pract. 2013;7(2):e129–38.

    Article  PubMed  Google Scholar 

  36. Liu L, Yan M, Yang R, Qin X, Chen L, Li L, et al. Adiponectin attenuates lipopolysaccharide-induced apoptosis by regulating the Cx43/PI3K/AKT pathway. Front Pharmacol. 2021;12:644225.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M, et al. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 2003;24(24):2186–96.

    Article  PubMed  Google Scholar 

  38. Bäck M, Yurdagul A, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389–406.

    PubMed  PubMed Central  Google Scholar 

  39. França LFC, Vasconcelos ACCG, da Silva FRP, Alves EHP, Carvalho JS, Lenardo DD, et al. Periodontitis changes renal structures by oxidative stress and lipid peroxidation. J Clin Periodontol. 2017;44(6):568–76.

    Article  PubMed  Google Scholar 

  40. Nepomuceno R, Pigossi SC, Finoti LS, Orrico SRP, Cirelli JA, Barros SP, et al. Serum lipid levels in patients with periodontal disease: a meta-analysis and meta-regression. J Clin Periodontol. 2017;44(12):1192–207.

    Article  PubMed  Google Scholar 

  41. Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes. 2010;59(5):1153–60.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Chapman MJ. HDL functionality in type 1 and type 2 diabetes: new insights. Curr Opin Endocrinol Diabetes Obes. 2022;29(2):112–23.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Many people have offered me valuable help in my this writing, including my tutor, my classmates. So I would like to give my sincere gratitude to Prof. Ren xiuyun, and my classmates.

Funding

The study was supported by grants from the National Natural Science Foundations of China (No.81271144). Excellent Achievements (Science and Technology) Cultivation Project of Shanxi Colleges and Universities (2020KJ014). Local Science and Technology Development Fund Project guided by the Central Government of Shanxi Provincial Department of Science and Technology (YDZX20201400001131).

Author information

Authors and Affiliations

  1. Department of Endocrinology, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, 030001, Shanxi Province, China

    Rui Cheng

  2. Shanxi Medical University, 56 Xinjian South Road, Taiyuan, 030001, Shanxi Province, China

    Rui Cheng, Xiaojiang Xu, Shurong Yang & Zhongqian mi

  3. Shanxi Medical University School and Hospital of Stomatology, 63# Xinjian South Road, Taiyuan, 030001, Shanxi Province, People’s Republic of China

    Xiaojiang Xu, Shurong Yang, Zhongqian mi, Yong Zhao, Chong Wang, Xuexue Shi, Jinhua Gao, Feiyan Yu & Xiuyun Ren

  4. Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Taiyuan, 030001, China

    Xiaojiang Xu, Shurong Yang, Zhongqian mi, Feiyan Yu & Xiuyun Ren

Authors
  1. Rui Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaojiang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shurong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhongqian mi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yong Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xuexue Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jinhua Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Feiyan Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiuyun Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study conception or design: XYR, FYY, JHG; data analyzing and draft manuscript preparation: RC, XJX; critical revision of the paper: SRY, ZQM, XXS; Supervision of the research: CW, YZ; final approval of the version to be published (the names of all authors must be listed): RC, XJX, SRY, ZQM, XXS, YZ, CW, JHG, FYY, XYR. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xiuyun Ren.

Ethics declarations

Ethics approval and consent for participate

All rats were maintained under standard housing conditions following the protocol approved by the Institutional Committee for Animal Use and Care at Shanxi medical university (No. 2018LL346).

Consent to publication

I consent to publish.

Competing interests

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

ARRIVE Guideline.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, R., Xu, X., Yang, S. et al. The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA. BMC Oral Health 23, 85 (2023). https://doi.org/10.1186/s12903-023-02765-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12903-023-02765-x

Keywords

BMC Oral Health

ISSN: 1472-6831

Contact us